As of 2026-03-18, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (4.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.24 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -461.4%.
The range of the Relative Valuation is (4.02) - (4.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 23.6x | 21.1x |
| Forward P/E multiples | 18.3x - 22.2x | 21.5x |
| Fair Price | (4.02) - (4.68) | (4.48) |
| Upside | -424.4% - -477.0% | -461.4% |
| Date | P/E |
| 2026-03-13 | -19.61 |
| 2026-03-12 | -22.20 |
| 2026-03-11 | -23.48 |
| 2026-03-10 | -23.81 |
| 2026-03-09 | -25.00 |
| 2026-03-06 | -22.81 |
| 2026-03-05 | -22.10 |
| 2026-03-04 | -24.69 |
| 2026-03-03 | -24.29 |
| 2026-03-02 | -26.71 |
| 2026-02-27 | -25.95 |
| 2026-02-26 | -26.14 |
| 2026-02-25 | -26.09 |
| 2026-02-24 | -24.76 |
| 2026-02-23 | -23.72 |
| 2026-02-20 | -23.53 |
| 2026-02-19 | -24.14 |
| 2026-02-18 | -23.86 |
| 2026-02-17 | -24.48 |
| 2026-02-13 | -25.09 |
| 2026-02-12 | -24.95 |
| 2026-02-11 | -25.28 |
| 2026-02-10 | -26.05 |
| 2026-02-09 | -26.43 |
| 2026-02-06 | -26.28 |
| 2026-02-05 | -24.19 |
| 2026-02-04 | -24.81 |
| 2026-02-03 | -25.71 |
| 2026-02-02 | -25.81 |
| 2026-01-30 | -25.47 |
| 2026-01-29 | -25.28 |
| 2026-01-28 | -25.76 |
| 2026-01-27 | -26.33 |
| 2026-01-26 | -24.86 |
| 2026-01-23 | -24.67 |
| 2026-01-22 | -24.81 |
| 2026-01-21 | -23.72 |
| 2026-01-20 | -22.58 |
| 2026-01-16 | -22.01 |
| 2026-01-15 | -20.96 |
| 2026-01-14 | -20.15 |
| 2026-01-13 | -19.68 |
| 2026-01-12 | -19.63 |
| 2026-01-09 | -19.53 |
| 2026-01-08 | -19.87 |
| 2026-01-07 | -19.77 |
| 2026-01-06 | -19.30 |
| 2026-01-05 | -20.15 |
| 2026-01-02 | -22.20 |
| 2025-12-31 | -24.62 |